| | SLO | ENG | Cookies and privacy

Bigger font | Smaller font
First page > Show document

Show document Help

Title:Genetski dejavniki in rak prostate (vpliv polimorfizmov C825T v genu GNB3 in D85Y v genu UGT2B15)
Authors:ID Hajdinjak, Tine (Author)
ID Zagradišnik, Boris (Author)
ID Kokalj-Vokač, Nadja (Author)
ID Kisner, Karel (Author)
Files:URL http://www.dlib.si/details/URN:NBN:SI:doc-NSDIHVU7
 
Language:Slovenian
Work type:Not categorized
Typology:1.01 - Original Scientific Article
Organization:UM - University of Maribor
Abstract:Izhodišča. V Sloveniji odkrijemo približno polovico manj raka prostate (CaP) kot v Avstriji. S staranjem prebivalstva in zlasti širjenjem osveščenosti se incidenca veča. Načini zdravljenja lahko močno poslabšajo kakovost življenja. Poteka bolezni ni moč natančno napovedati. Glavni dejavnik tveganja za CaP je dednost, zato je eden od načinov iskanja novih napovednih dejavnikov analiza polimorfizmov posameznih nukleotidov (SNP). Metode. DNK smo osamili iz periferne krvi 86 bolnikov s histološko verificiranim rakom prostate in 178 kontrol. Polimorfizma D85Y v genu UGT2B15 in C825T v genu GNB3 smo določali z metodo RFLP. Frekvence posameznih alelov smo primerjali med bolniki in zdravimi ter znotraj skupine bolnih glede na oceno po Gleasonu (pod 7 in 7 ali več). Rezultati. D85Y: bolniki: 23% DD, 49% DY, kontrolie: 16% DD, 52% DY (nz). Med bolniki z oceno po Gleasonu 7 ali več je bil delež DD 33%, pod 7 pa 14% (tveganje za DD 2,97, p = 0,041). C825T: bolniki: 14% TT, 44% CT, kontrole 8% TT, 46% CT(nz). Zaključki. Vpliva preučevanih polimorfizmov na tveganje za nastanek CaP nismo potrdili, ugotovili pa smo značilno večji delež alela D polimorfizma D85Y znotraj podskupine bolnikov s slabše diferenciranim rakom. Ta bi lahko postal eden od napovednih dejavnikov pri odkrivanju in zdravljenju CaP.
Year of publishing:2004
Number of pages:str. 481-484
Numbering:Letn. 73, št. 6
PID:20.500.12556/DKUM-56141 New window
UDC:616-006
ISSN on article:1318-0347
COBISS.SI-ID:1612607 New window
NUK URN:URN:SI:UM:DK:4LR1QTP4
Publication date in DKUM:21.12.2015
Views:2324
Downloads:54
Metadata:XML DC-XML DC-RDF
Categories:Misc.
:
HAJDINJAK, Tine, ZAGRADIŠNIK, Boris, KOKALJ-VOKAČ, Nadja and KISNER, Karel, 2004, Genetski dejavniki in rak prostate (vpliv polimorfizmov C825T v genu GNB3 in D85Y v genu UGT2B15). Zdravniški vestnik. glasilo Slovenskega zdravniškega društva [online]. 2004. Vol. 73, no. 6, p. 481–484. [Accessed 3 April 2025]. Retrieved from: http://www.dlib.si/details/URN:NBN:SI:doc-NSDIHVU7
Copy citation
  
Average score:
0.5
1
1.5
2
2.5
3
3.5
4
4.5
5
(0 votes)
Your score:Voting is allowed only for logged in users.
Share:Bookmark and Share


Searching for similar works...Please wait....
Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Zdravniški vestnik. glasilo Slovenskega zdravniškega društva
Publisher:Slovensko zdravniško društvo
ISSN:1318-0347
COBISS.SI-ID:32893696 New window

Secondary language

Language:English
Title:Genetic factors and prostate cancer (influence of single nucleotide polymorphisms C825T in gene GNB3 and D85Y in gene UGT2B15)
Abstract:Background. In Slovenia, incidence of prostate cancer (CaP) is approximately half of incidence in neighbouring Austria. With ageing of population and increasing awareness, incidence is increasing. Treatment of CaP can drastically decrease quality of life and course of disease is not possible to predict. As main risk factor for CaP is heredity, one way of looking for prognostic factors is evaluation of influence of single nucleotide polymorphisms (SNPs). Methods. DNA was isolated from peripheral blood of 86 patients with histologically proven prostate cancer and 178 controls. Polymorphisms D85Y in gene UGT2B15 and C825T in gene GNB3 were evaluated with RFLP. Frequencies of alleles were compared between controls and patients and between patients stratified according to the Gleason score (less than 7 and 7 or more). Results. D85Y: patients: 23% DD, 49% DY, controls 16% DD, 52% DY (NS). In patients with Gleason score 7 or more frequency of DD was 33% and with Gleason score less than 7 15% (risk ratio for DD 2.97, p = 0.041). C825T: patients: 14% TT, 44% CT, controls 8% TT, 46% CT (NS). Conclusions. Although study did not confirm influence of evaluated polymorphisms on risk for developing prostate cancer, we identified significantly higher frequency of D allele of polymorphism D85Y in subgroup of patients with poorly differentiated CaP. This polymorphism could become one of the prognostic factors in CaP.


Comments

Leave comment

You must log in to leave a comment.

Comments (0)
0 - 0 / 0
 
There are no comments!

Back
Logos of partners University of Maribor University of Ljubljana University of Primorska University of Nova Gorica